Monocyte count and decline in forced vital capacity (FVC) in patients with IPF
A. Tzouvelekis (Athens, Greece), T. Maher (London, United Kingdom), N. Goh (Melbourne, Victoria, Australia), M. Kreuter (Heidelberg, Germany), V. Cottin (Lyon, France), B. Schinzel (Ingelheim am Rhein, Germany), L. Orsatti (Ingelheim am Rhein, Germany), T. Corte (Sydney, New South Wales, Australia)
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tzouvelekis (Athens, Greece), T. Maher (London, United Kingdom), N. Goh (Melbourne, Victoria, Australia), M. Kreuter (Heidelberg, Germany), V. Cottin (Lyon, France), B. Schinzel (Ingelheim am Rhein, Germany), L. Orsatti (Ingelheim am Rhein, Germany), T. Corte (Sydney, New South Wales, Australia). Monocyte count and decline in forced vital capacity (FVC) in patients with IPF. 721
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019
The acceptability criterion for the difference between the forced inspiratory vital capacity (FIVC) and the forced vital capacity (FVC) are too strict? Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021
Is the forced expiratory volume in 6 seconds (FEV6 ) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients Source: Eur Respir J 2001; 18: Suppl. 33, 13s Year: 2001
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017
Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity Source: Eur Respir J 2008; 31: 391-395 Year: 2008
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
The inclusion of peak expiratory flow (PEF) among selection criteria of the ”best test“ may increase diagnostic ability of forced vital capacity (FVC) Source: Eur Respir J 2001; 18: Suppl. 33, 202s Year: 2001
Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients? Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012
Association between weight loss and decline in FVC in patients with IPF Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019
Forced expiratory volume in one second (FEV1 ) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011
Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010
Distinguishing hyperinflation from combined restriction in patients with reduced FEV1 /FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Midflows do not vary independently of FEV1 and FVC Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005
Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007